Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases
{{output}}
Clinical response to methotrexate (MTX) treatment for children with juvenile idiopathic arthritis (JIA) displays considerable heterogeneity. Currently, there are no reliable predictors to identify non-responders: earlier identification could lead to a targeted... ...
